Draig Therapeutics
Draig Therapeutics develops therapies for neuropsychiatric disorders.
$65M Series B+ ·
Led by Deep Track Capital · Source: fundraisingfox.com
Total raised: $205M across 2 sourced rounds
All 2 rounds ↓Signals
About Draig Therapeutics
The company creates neuromodulators designed to regulate neurotransmission pathways. Its pipeline includes DT-101 for major depressive disorder and other modulators for additional neuropsychiatric indications. Draig advances these programs through preclinical and clinical development for patients.
Draig Therapeutics | 482 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $65M | fundraisingfox.com | ||
| Seed | $140M | icgam.com |
Timeline
- Website created
Founders and team
JA
John Atack Head of Biology & FounderLinkedIn · source: draigtherapeutics.comRM
Ruth McKernan FounderLinkedIn · source: draigtherapeutics.comSW
Simon Ward Chief Scientific Officer & FounderLinkedIn · source: draigtherapeutics.comFI
Florian Islinger Chief Commercial Strategy OfficerIK
Inderjit Kaul Chief Medical OfficerIM
Ivana Magovčević-Liebisch President and Chief Executive OfficerWY
Weeteck Yeo SVP, Business Operations & Chief of Staff
Investors
BBritish Business Bank
CCanaan Partners
DDeep Track Capitallead investor
IIntermediate Capital Grouplead investor
JJanus Henderson Investors
JJefferson Life Sciences
MMarshall Wace
SSanofi Ventures
SSchroders Capital
SSV Health Investorslead investor
Companies like Draig Therapeutics
EEngrail Therapeutics$157M Series B+ · Mar 2024
CClaris Bio$118M Series B+ · Jul 2026
NNeurosterix$105M Series B+ · Nov 2026
AActio Biosciences$66M Series B+ · Jun 2025
SSplice Bio$140M Series B+ · Jun 2025
RReRx
Other companies backed by Deep Track Capital
EEstuary Biotherapeutics$103M Series A · Oct 2026
OOblenio Bio$62M Series B+ · Jun 2026
TTubulis$360M Series B+ · Oct 2025TTorl Bio$96M Series B+ · Oct 2025
AArbor Biotechnologies$74M Series B+ · Mar 2025
MMariana Oncology$175M Series B+ · Sep 2023
Deep Track Capital portfolio →
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/draig-therapeutics (get a free API key).